As of May 23
| +0.08 / +1.04%|
The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 27.00, with a high estimate of 33.00 and a low estimate of 20.00. The median estimate represents a +247.94% increase from the last price of 7.76.
The current consensus among 6 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.